Previous Page  3 / 76 Next Page
Show Menu
Previous Page 3 / 76 Next Page
Page Background


One fundamental mission

The National Comprehensive Cancer Network




) is

bound by one fundamental mission: to improve the quality,

effectiveness, and efficiency of cancer care so that patients can

live better lives. Patients inspire us—both as an organization

and an alliance—to continually advance patient care, research,

and education.

The alliance of NCCN Member Institutions grew in March 2016,

as we welcomed University of Wisconsin Carbone Cancer

Center, complementing the network with its outstanding

programs, such as its comprehensive palliative care program

that includes an in-patient unit and consultation service,

children’s hospital consultative services, and an outpatient

onco-palliative care clinic. We are excited to witness the growth

of the center’s impact within the alliance and across NCCN


Through the leadership of the 27 NCCN Member Institutions,

NCCN continues to advance cancer care through the

development and dissemination of the NCCN Clinical Practice

Guidelines in Oncology (NCCN Guidelines


). The NCCN



are comprised of recommendations for the

prevention, diagnosis, and management of malignancies across

the continuum of care. The NCCN Guidelines currently apply

to more than 97% of cancers affecting U.S. patients, and are

viewed as the basis for cancer policy in the United States. The

NCCN Guidelines are at the center of all we do. Reviewed and

updated at least annually, they incorporate real-time updates in

keeping with the rapid advancements in cancer care, ensuring

that the recommendations take into account the most current


Derived directly from the NCCN Guidelines, NCCN launched

its newest clinical resource in 2016—the NCCN Imaging

Appropriate Use Criteria (NCCN Imaging AUC


), which provide

a single source for appropriate imaging in the diagnosis and

treatment of patients with cancer. NCCN was recognized by

Centers for Medicare & Medicaid Services (CMS) in 2016 as an

Approved Provider-Led Entity for the development of Imaging

AUC. NCCN signed multiple licensing agreements for the

integration of the NCCN Imaging AUC™ in clinical decision

support mechanisms.

Paramount to ensuring patient access to quality care is

empowering patients and providers with evidence-based

information for use in the decision-making process. To that

end, NCCN publishes a library of NCCN Guidelines for



giving patients access to the same information that

their doctors use. It is our hope that patients can be active

participants in the shared decision-making process, choosing

treatment plans in line with their personal values. In 2016,

NCCN published 10 new patient guidelines, the most in a single

year in our history.

NCCN continues to collaborate with health information

technology stakeholders to disseminate via their technologies

the recommendations outlined in the NCCN Guidelines

and their derivatives at the point of care. To improve patient

safety and standardize treatment plans, NCCN was happy to

announce in 2016 its collaboration with Cerner Corporation to

integrate the NCCN Chemotherapy Order Templates (NCCN



) into its electronic health record. Additionally, NCCN

signed an agreement with the American Cancer Society (ACS)

for the use of the NCCN Templates


and NCCN Guidelines

for the development of an online chemotherapy forecasting

tool—ChemoQuant—to assist African ministries of health with

creating high-quality forecasts of cancer-related medicines.

More information about this project will be announced in 2017.

NCCN Annual Report 2016

Message from the Chair of the NCCN Board of Directors and Chief Executive Officer